Bosca A R, Tinois E, Faure M, Kanitakis J, Roche P, Thivolet J
Servicio de Dermatologia, Facultad de Medicina, Valencia, Espana.
J Invest Dermatol. 1988 Aug;91(2):136-41. doi: 10.1111/1523-1747.ep12464379.
Human skin equivalents were developed in vitro with a unidimensionally retracted dermal equivalent made of human type I + III collagen and human MRC5 fibroblasts, and a multilayered epithelium grown in liquid medium from normal human keratinocytes in suspension. We investigated the degree of epidermal differentiation that could be achieved after in vivo grafting onto nude mice by means of light and electronmicroscopy as well as by immunohistochemistry. All transplanted grafts showed a primary take. The grafts formed an epidermis with a stratum corneum and from day 7 to 14 after transplantation a distribution of a 56.5 Kd keratin protein, involucrin, profilaggrin/filaggrin, and MHC-I antigens that was similar to what is noted in normal human epidermis. These data indicate that a full terminal differentiation was only achieved after in vivo transplantation of the cultured epithelium. Pigmentation was present, but no marker of Langerhans cells was seen at 4 weeks. Although there was no evidence of the dermal equivalent after 2 weeks, we noted a strong adherence of the graft to the wound bed, with the presence of type-IV collagen, laminin, and bullous pemphigoid antigen at the dermo-epidermal junction (day 7) and hemidesmosomes, a lamina lucida and a lamina densa (day 30). No epithelial damage was noted in spite of an inflammatory infiltrate in the underlying tissue. This represents a preliminary step in the use of such a skin-equivalent in the treatment of human patients with wounds.
用人I型+III型胶原蛋白和人MRC5成纤维细胞制成的一维收缩真皮等效物以及由悬浮培养的正常人角质形成细胞在液体培养基中生长的多层上皮在体外构建人皮肤等效物。我们通过光学显微镜、电子显微镜以及免疫组织化学研究了体内移植到裸鼠后可实现的表皮分化程度。所有移植的移植物均出现一期存活。移植物形成了带有角质层的表皮,并且在移植后第7天至14天,一种56.5 Kd角蛋白、兜甲蛋白、前丝聚蛋白/丝聚蛋白和MHC-I抗原的分布与正常人表皮中的情况相似。这些数据表明,培养的上皮在体内移植后才实现了完全终末分化。存在色素沉着,但在4周时未见朗格汉斯细胞标记物。尽管2周后没有真皮等效物的证据,但我们注意到移植物与创面床紧密粘连,在真皮-表皮交界处(第7天)存在IV型胶原、层粘连蛋白和大疱性类天疱疮抗原,并且在第30天存在半桥粒、透明层和致密层。尽管底层组织有炎性浸润,但未观察到上皮损伤。这是在将这种皮肤等效物用于治疗人类伤口患者方面迈出的初步步骤。